Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph not_applicable
1
25%
Ph phase_4
2
50%
Ph phase_2
1
25%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 4Post-market surveillance
2(50.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Other(4)

Detailed Status

unknown4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 21 (25.0%)
Phase 42 (50.0%)
N/A1 (25.0%)

Trials by Status

unknown4100%

Recent Activity

0 active trials
Showing 4 of 4
unknownphase_4

Study of Collateral Circulation in Patients With Symptomatic Intracranial Anterior Circulation Occlusion

NCT04091412
unknownnot_applicable

A Clinical Study on the Treatment of Cerebral Small Vascular Disease

NCT04078204
unknownphase_2

The Efficacy of Butylphthalide Soft Capsules in Patents With VCIND

NCT02993367
unknownphase_4

The Effectiveness and Safety of Butylphthalide Soft Capsules in Secondary Prevention of Ischemic Stroke Trial

NCT00724724

Clinical Trials (4)

Showing 4 of 4 trials
NCT04091412Phase 4

Study of Collateral Circulation in Patients With Symptomatic Intracranial Anterior Circulation Occlusion

Unknown
NCT04078204Not Applicable

A Clinical Study on the Treatment of Cerebral Small Vascular Disease

Unknown
NCT02993367Phase 2

The Efficacy of Butylphthalide Soft Capsules in Patents With VCIND

Unknown
NCT00724724Phase 4

The Effectiveness and Safety of Butylphthalide Soft Capsules in Secondary Prevention of Ischemic Stroke Trial

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4